2023
Entrant Company
Category
Client's Name
Country / Region
Unlocking the Proteome -The NULISA™ Platform sets a new standard in proteomic analysis with attomolar sensitivity, allowing for unprecedented biomarker detection and quantitation.
By leveraging a proprietary sequential immunocomplex capture and release mechanism and the latest advances in Next Generation Sequencing (NGS), the NULISA technology provides both ultra-high sensitivity and scalable multiplexing.
Credits
Entrant Company
Karthik Bujuru
Category
Conceptual Design - Conceptual
Country / Region
United States
Entrant Company
Matter
Category
Branded Content - Brand Journalism
Country / Region
United States
Entrant Company
Chugai Pharmaceuticals
Category
Strategic Program - Research / Study
Country / Region
United States
Entrant Company
SFC Group
Category
Marketing Campaign - Integrated Marketing Campaign
Country / Region
United States